Medicus Pharma Ltd. (MDCX) earnings
MDCX earnings moved a median of 0.00% by the close. Quarterly and annual MDCX reports and results, each read against the price at its own news timestamp. Back to the MDCX overview →
12 measured MDCX earnings events.
Where these MDCX earnings landedvs 11 measured MDCX earnings reactions
| Middle 50% of MDCX earnings reactions | -2.29% to +5.56% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 MDCX earnings events with a measured close landed between -2.29% and +5.56%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Medicus Pharma Ltd. For: Jun 30 | SEC filing · Form 10-Q | -1.78% | +6.95% | |
| Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | -1.78% | +6.95% | |
| Form 10-Q Medicus Pharma Ltd. For: Mar 31 | SEC filing · Form 10-Q | -0.64% | -4.44% | |
| Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.64% | -4.44% | |
| Form 10-K/A Medicus Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | +0.11% | -0.14% | |
| Form 10-K Medicus Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | +1.62% | -6.86% | |
| Form 10-Q Medicus Pharma Ltd. For: Sep 30 | SEC filing · Form 10-Q | +0.87% | +0.00% | |
| Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights | Press release | +0.87% | +0.00% | |
| Form 10-Q Medicus Pharma Ltd. For: Jun 30 | SEC filing · Form 10-Q | +2.04% | — | |
| Form 10-Q Medicus Pharma Ltd. For: Mar 31 | SEC filing · Form 10-Q | +5.49% | +4.17% | |
| Form 10-K/A Medicus Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | — | +2.31% | |
| Form 10-K Medicus Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +14.81% |
Keep exploring
More MDCX: analyst actions → · SEC filings → · MDCX overview →